Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator

A legfontosabb adatok

Ki végzi
The Cleveland Clinic
Hol
Cleveland (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Leállítva
Résztvevők
2 fő vett részt
Kezdés
2025. okt. 1.
Befejezés
2026. febr. 1.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • Vasopressin
A regiszteradat frissítve
2026. február 19.
Miért állt le
The study was terminated due to lack of feasibility.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 13 feltétel megnézéseKevesebb

Ki vehet részt

  • Adult patients (≥18 years old)
  • Septic shock (as defined by Sepsis-3)
  • Receiving norepinephrine
  • Admitted to a medical, surgical, NeuroSciences, or mixed intensive care unit
  • Central venous catheter in place
  • Ordered fixed-dose vasopressin as an adjunct to norepinephrine by the primary care team (unless in active control cohort)

Ki nem vehet részt

  • Receiving a primary vasopressor other than norepinephrine (eg, phenylephrine)
  • Positive test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the preceding 28 days
  • Blood hemoglobin concentration <7 g/dL
  • Vasopressin ordered for an indication other than septic shock
  • Vasopressin initiated at another institution
  • Primary treatment team determines that vasopressin initiation is emergent
  • Patient or their legal authorized representative opts to not participate in the study

Helyszínek itt: Egyesült Államok

  • Cleveland Clinic - Main CampusCleveland, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this observational study is to learn about blood pressure response to the vasopressor drug vasopressin in people with septic shock.

A teljes eredeti leírásKevesebb

The main questions it aims to answer are:

* Are the levels of molecules showing communication between cells different between people whose blood pressure improves and people whose blood pressure does not improve when given a vasopressor medication? * Are measurements found on echocardiography (heart ultrasound) different between people whose blood pressure improves and people whose blood pressure does not improve when given a vasopressor medication? * Are measurements of blood oxygen in tissues just below the skin different between people whose blood pressure improves and people whose blood pressure does not improve when given a vasopressor medication?

Participants will be asked to contribute one or two blood samples. Participants who are ordered the drug vasopressin will contribute two blood samples. Both samples will be about two tablespoons for a total of about four tablespoons. One sample will be drawn before starting vasopressin infusion and the second sample will be drawn between one and six hours after starting the vasopressor drug infusion. At the same time points, advanced echocardiography pictures and measurements of oxygen in tissues from a sensor placed on one of the hands will be taken. Participants who are not ordered the drug vasopressin and only ordered the drug norepinephrine will contribute only one blood sample. At the time the sample is collected, advanced echocardiography pictures and measurements of oxygen in tissues from a sensor placed on one of the hands will be taken. This research also involves analyzing data obtained during the participant's hospital stay.

A vizsgálat 2 csoportja

  • Vasopressin plus norepinephrine

    Patients with septic shock ordered vasopressin as an adjunct to norepinephrine

    Kezelés: Vasopressin

  • Norepinephrine

    Active control cohort of patients with septic shock who are only receiving norepinephrine

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. február 19.